Mannkind (MNKD) EPS (Basic) Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | 16.06% |
| Sep 30, 2025 | 21.06% |
| Jun 30, 2025 | 15.37% |
| Mar 31, 2025 | 24.57% |
| Dec 31, 2024 | 19.42% |
| Sep 30, 2024 | 22.87% |
| Jun 30, 2024 | 32.24% |
| Mar 31, 2024 | 20.11% |
| Dec 31, 2023 | 16.72% |
| Sep 30, 2023 | 15.58% |
| Jun 30, 2023 | 34.02% |
| Mar 31, 2023 | 30.69% |
| Dec 31, 2022 | 24.21% |
| Sep 30, 2022 | 28.00% |
| Jun 30, 2022 | 20.66% |
| Mar 31, 2022 | 10.07% |
| Dec 31, 2021 | -17.04% |
| Sep 30, 2021 | -15.04% |
| Jun 30, 2021 | 15.76% |
| Mar 31, 2021 | 29.64% |
| Dec 31, 2020 | 28.89% |
| Sep 30, 2020 | 33.69% |
| Jun 30, 2020 | 32.62% |
| Mar 31, 2020 | 12.94% |
| Dec 31, 2019 | 4.90% |
| Sep 30, 2019 | 11.09% |
| Jun 30, 2019 | 18.10% |
| Mar 31, 2019 | 10.59% |
| Dec 31, 2018 | 17.81% |
| Sep 30, 2018 | 1.21% |
| Jun 30, 2018 | 0.00% |
| Mar 31, 2018 | -10.76% |
| Dec 31, 2017 | -4.01% |
| Sep 30, 2017 | -7.10% |
| Jun 30, 2017 | -8.76% |
| Mar 31, 2017 | 8.84% |
| Dec 31, 2016 | 31.06% |
| Sep 30, 2016 | 44.31% |
| Jun 30, 2016 | 2.26% |
| Mar 31, 2016 | 3.13% |
| Dec 31, 2015 | -14.87% |
| Sep 30, 2015 | 0.51% |
| Jun 30, 2015 | 0.55% |